30 May 2025

We’re thrilled to share some exciting news — Koru Pharma has been featured in Inc. magazine in a powerful new article spotlighting South Korea’s booming aesthetic tech scene!

Titled “The Case for Building Quietly: What South Korea’s Aesthetic Tech Boom Reveals About Sustainable Scale”, the piece explores how true innovation doesn’t always shout — it builds, grows, and lasts. And we’re proud to say Koru Pharma is front and centre in this global conversation.

“One company surfaced repeatedly… Koru Pharma, a Seoul-based aesthetic biotech firm preparing for a public offering… offering global reach, IP-driven growth, and a long view on market development.” — Inc. Magazine

As Inc. highlights, what sets us apart isn’t just what we do — it’s how we do it. From our non-invasive anti-ageing innovations to our distribution network spanning 100+ countries, Koru Pharma is proving that aesthetic biotech can scale globally — sustainably, strategically, and smartly.

The article features our recent pre-IPO investment from KB Investment, one of South Korea’s most respected institutional funds. It’s a clear vote of confidence in our mission to make science-led aesthetic health a serious, long-term force in global wellness.

Why does this matter? Because in a world full of noise, we believe in building something that lasts. We’re not chasing trends - we’re creating the future of beauty and regenerative medicine with real science and global vision.

Read the full article on Inc. here: https://www.inc.com/natacha-rousseau/the-case-for-building-quietly/91196179

A huge thank you to our clients, partners, and supporters around the world. This recognition belongs to all of you.